AZN Share PerformanceMore
|52 week high||5,520 22/06/17|
|52 week low||3,680 24/06/16|
|52 week change||1,503 (38.54%)|
|4 week volume||34,458,099 29/05/17|
Latest News« previous» nextMore
23/06/2017 - 12:46 RNS
RNS Number: 0368J AstraZeneca PLC 23 June 2017 23 June 2017 12:45BST FASLODEX (FULVESTRANT) RECEIVES POSITIVE CHMP OPINION FOR USE IN 1st-LINE HORMONE RECEPTOR-POSITIVE ADVANCED BREAST CANCER CHMP positive recommendation is based on Phase III data demonstrating a 20% reduction in risk of disease worsening or d...
16/06/2017 - 08:50 StockMarketWire
Jefferies International today reaffirms its hold investment rating on AstraZeneca PLC (LON:AZN) and raised its price tar...
07/06/2017 - 16:46 StockMarketWire
Oil prices plummeted by at least 3% after the Energy Information Administration suggested supply outstripped demand a...
07/06/2017 - 11:54 StockMarketWire
The FTSE 100 defied subdued trading in the US and Asia ahead of the UK general election on Thursday thanks to a rally i...
07/06/2017 - 07:19 StockMarketWire
AstraZeneca has entered an agreement with Grunenthal for the global rights to Zomig (zolmitriptan) outside Japan. Zomig...
07/06/2017 - 07:13 RNS
RNS Number: 3790H AstraZeneca PLC 07 June 2017 7 June 2017 ASTRAZENECA ENTERS AGREEMENT WITH GRNENTHAL TO DIVEST RIGHTS TO MIGRAINE TREATMENT ZOMIG AstraZeneca today announced that it has entered an agreement with Grnenthal for the global rights to Zomig (zolmitriptan) outside Japan. Zomig is indicated for the acute...
06/06/2017 - 07:00 RNS
RNS Number: 2066H AstraZeneca PLC 06 June 2017 6 June 2017 07:00 BST ASTRAZENECA PRICES A $2BN BOND ISSUE AstraZeneca PLC announces that, on 5 June 2017, it priced a three tranche Global bond offering totalling $2bn. The offering is expected to close on 12 June 2017, subject to customary closing conditions. AstraZeneca expects to use the net proceed...
05/06/2017 - 16:49 StockMarketWire
Gains in Brent crude oil prices earlier today went into reverse, with oil hitting $49.17 per barrel. Prices initially strengthened...
Latest discussion posts More
“Extracts: AstraZeneca will face a ?substantial setback? if its most ambitious foray into cutting edge immunotherapy falls flat, its chief executive Pascal Soriot has ...”▼
“Hi Proverbs, FT is paywalled, any chance of a topline summary? Thanks”▼
Codes & Symbols
|Symbols||AZN, LSE:AZN, AZN.L, AZN:LN, LON:AZN, XLON:AZN|